ELEVATE | From Research to Recovery: CAR T-Cell Therapy for Myeloma Patients

How has CAR T-cell therapy for myeloma changed in recent years? Dr. Ciara Freeman, a myeloma specialist at Moffitt Cancer Center, will discuss myeloma CAR T-cell therapy highlights from the recent meeting of the American Society of Hematology (ASH) and how these advances are impacting patient care. Dr. Freeman will also share advice for preparing for CAR T-cell therapy and what to expect following the process.